NCT03178591View on ClinicalTrials.gov

Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Diabetes Mellitus, Type 2Ischemic Heart Disease
Interventions
DRUG

vildagliptin

DRUG

Dapagliflozin

Trial Locations (1)

50200

Faculty of Medicine, Chiang Mai University, Chiang Mai

All Listed Sponsors
lead

Chiang Mai University

OTHER

NCT03178591 - Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor | Biotech Hunter | Biotech Hunter